We are live on ! Find out more
IART icon

Integra LifeSciences
IART

264 hedge funds and large institutions have $5.09B invested in Integra LifeSciences in 2021 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 95 increasing their positions, 77 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

31% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 29

23% more repeat investments, than reductions

Existing positions increased: 95 | Existing positions reduced: 77

3% more funds holding

Funds holding: 257 → 264 (+7)

0.95% more ownership

Funds ownership: 87.5% → 88.46% (+0.95%)

0% more capital invested

Capital invested by funds: $5.09B → $5.09B (+$4.06M)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
264
Holders Change
+7
Holders Change %
+2.72%
% of All Funds
4.6%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
38
Increased
95
Reduced
77
Closed
29
Calls
$1.71M
Puts
–
Net Calls
+$1.71M
Net Calls Change
+$1.23M

Top Buyers

1
EVM
Eaton Vance Management
Massachusetts
+$14.8M
2
First Trust Advisors
First Trust Advisors
Illinois
+$12.5M
3
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
+$11.9M
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$11.6M
5
Macquarie Group
Macquarie Group
Australia
+$11.4M

Top Sellers

1
Invesco
Invesco
Georgia
-$17.9M
2
Millennium Management
Millennium Management
New York
-$14.3M
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$7.63M
4
MPAM
Monarch Partners Asset Management
Massachusetts
-$5.71M
5
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$5.49M
Name Holding Trade Value Shares
Change 		Change in
Stake
MOS
176
MGO One Seven
Ohio
$349K – – –
QCM
177
Quantinno Capital Management
New York
$347K – – –
CCA
178
Conestoga Capital Advisors
Pennsylvania
$341K – – –
CS
179
Cannell & Spears
New York
$327K +$82K +1,159 +32%
PA
180
Profund Advisors
Maryland
$325K +$2.4K +34 +0.7%
Bessemer Group
181
Bessemer Group
New Jersey
$323K – – –
PAMU
182
Pictet Asset Management (UK)
United Kingdom
$321K -$63.6K -900 -16%
CCIA
183
Campbell & Co Investment Adviser
Maryland
$319K +$330K +4,669 New
PG
184
Pendal Group
Australia
$307K +$318K +4,500 New
NIPH
185
NN Investment Partners Holdings
Netherlands
$300K +$311K +4,400 New
NIC
186
Northwest Investment Counselors
Oregon
$299K – – –
SM
187
Sciencast Management
New Jersey
$287K +$298K +4,212 New
PAG
188
Private Advisor Group
New Jersey
$278K +$30.7K +434 +12%
BC
189
Burney Company
Virginia
$275K -$5.66K -80 -2%
SLG
190
Stanley-Laman Group
Pennsylvania
$273K – – –
GT
191
Glenmede Trust
Pennsylvania
$273K +$8.91K +126 +3%
SCM
192
Shelton Capital Management
Colorado
$270K – – –
CAPTRUST Financial Advisors
193
CAPTRUST Financial Advisors
North Carolina
$264K -$4.17K -59 -2%
CT
194
Cambridge Trust
Massachusetts
$262K -$72.3K -1,023 -21%
JG
195
Jefferies Group
New York
$258K +$268K +3,786 New
ACM
196
AlphaCrest Capital Management
New York
$248K +$45.6K +645 +22%
PAM
197
Panagora Asset Management
Massachusetts
$245K -$12.7K -179 -5%
WT
198
Whittier Trust
California
$228K – – –
FIM
199
Freedom Investment Management
Connecticut
$214K +$13.9K +197 +7%
CIBC Asset Management
200
CIBC Asset Management
Ontario, Canada
$211K – – –
6 7
8
9 10

IART Hedge Fund Activity: Q2 2021 in Review

264 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Integra LifeSciences (IART) for Q2 2021, worth a combined $5.09B — up 0.08% from $5.09B a quarter earlier.

Buyers outnumbered sellers: 38 funds opened new IART positions and 29 closed out — a net gain of 9 holders — while 95 added to existing stakes and 77 trimmed.

The largest buyer was Eaton Vance Management, adding an estimated $14.8M. The largest seller was Invesco, cutting an estimated $17.9M.

  • 264 institutional investors held Integra LifeSciences (IART) as of Q2 2021, up from 257 in Q1 2021.
  • Funds reported $5.09B of Integra LifeSciences stock for Q2 2021, up 0.08% quarter-over-quarter.
  • 38 funds opened new Integra LifeSciences positions in Q2 2021 and 29 closed out, a net change of +9 holders.
  • The largest Integra LifeSciences buyer in Q2 2021 was Eaton Vance Management, an estimated $14.8M added.
  • The largest Integra LifeSciences seller in Q2 2021 was Invesco, an estimated $17.9M sold.

Based on aggregated 13F filings for Q2 2021.